Implied Podcast

AST SpaceMobile just took a massive hit, dropping 11.6% after Elon Musk’s SpaceX reportedly snatched up the highly coveted 800 MHz spectrum block it desperately needed. With a painful $230 million net loss, recent share dilution, and heavy insider selling, Wall Street is hitting the panic button on the direct-to-cell startup. But with a $2.7 billion war chest, 13 satellites already in orbit, and a $1.3 billion revenue backlog, AST isn't running on fumes just yet. In this episode of Implied, we break down what this fierce rivalry means for the telecom world and whether this massive selloff is a red flag… or a rare buy-the-dip opportunity for long-term value hunters.

Planet Fitness has taken a heavy beating over the last year, plummeting over 50% from its 52-week high of $114 down to the low-$50s. But beneath the Wall Street noise, the underlying data reveals a classic value setup. Despite macro headwinds, the gym giant just beat Q2 earnings, proved strong pricing power after raising member fees by 50%, and sparked a massive insider buying spree from the CEO and board members. In this episode of Implied, we break down whether Wall Street has severely mispriced $PLNT's resilient franchise model—or if tightening consumer budgets pose a real threat. Tune in to see if this steep selloff signals danger or a rare chance to buy high-margin growth on sale.

Novo Nordisk shares just plummeted 8% after management’s Capital Markets Day left Wall Street underwhelmed by its growth targets through 2030. Despite trading at a bargain P/E of 9.7 with a solid 4% dividend yield, investors panicked over the upcoming 2032 Wegovy and Ozempic patent cliff, slowing prescription growth, and mounting competition from Eli Lilly. In this episode of Implied, we break down whether this steep selloff is an emotional Wall Street overreaction that creates a classic value entry point—or a warning that the pharma giant’s explosive growth era is coming to an end. Tune in for the full story behind the drop!

Enova International just suffered a brutal 22% single-day crash after scrapping its $369 million acquisition of Grasshopper Bancorp—killing its shortcut to a coveted bank charter. But while traders panicked, Enova’s core lending business is thriving, with management reaffirming 30% earnings growth and backed by $349 million in buybacks. In this episode of Implied, we break down why regulators stalled the deal, why top analysts are keeping their Buy ratings, and whether this steep selloff is a Wall Street temper tantrum that created a rare bargain.

Walmart stock just suffered a brutal 9% nose-dive, even after beating earnings estimates with an adjusted EPS of $0.81. The culprit? U.S. same-store sales growth hit a 6-year low at just 2.6%, sparking fears that budget-conscious shoppers are finally pulling back. In this episode of Implied, we break down why a defensive powerhouse with $187.9B in quarterly revenue got hammered by Wall Street, how intense rivalry from Target and Amazon is squeezing margins, and whether Walmart's aggressive price cuts on 11,000+ items make this crash a rare buying opportunity—or a warning sign for the broader economy. Tune in to uncover the story behind today's massive market reaction!